• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025

    1/30/25 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care
    Get the next $SOLV alert in real time by email
    • Company to host an Investor Day in March 2025

    ST. PAUL, Minn., Jan. 30, 2025 /PRNewswire/ -- Solventum (NYSE:SOLV) will release its fourth quarter fiscal year 2024 financial results on Thursday, February 27, 2025, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2025 outlook. Other forward-looking and material information may also be discussed during the webcast.

    Solventum Logo (PRNewsfoto/3M Healthcare US Opco  LLC)

    Earnings webcast details:

    Date:

    Thursday, February 27, 2025

    Time:

    3:30 p.m. CST / 4:30 p.m. EST

    Location:

    https://investors.solventum.com

    U.S. dial-in

    +1 (800) 715-9871

    International dial-in:

    +1 (646) 307-1963

    Conference ID:

    6342275

    A replay of the webcast, the earnings press release, presentation slides, and supplemental financial disclosures, will be available on the Investor Relations section of Solventum's website.

    Other upcoming Investor Events:

    2025 Investor Day  

    Mid-March (location: NYC)

    Additional details to follow

    Solventum plans to host an Investor Day in March in New York City to introduce its strategy to accelerate growth and its long-range financial plan. More details and registration information will be shared soon.

    About Solventum

    At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-to-report-fourth-quarter-and-full-year-fiscal-2024-earnings-on-february-27-2025-302364744.html

    SOURCE Solventum

    Get the next $SOLV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SOLV

    DatePrice TargetRatingAnalyst
    6/6/2025Sector Weight
    KeyBanc Capital Markets
    5/19/2025$87.00Neutral → Overweight
    Piper Sandler
    12/4/2024$70.00Neutral
    Mizuho
    10/8/2024$82.00Buy
    Stifel
    10/7/2024$71.00Neutral
    Piper Sandler
    9/26/2024Peer Perform
    Wolfe Research
    9/5/2024Neutral
    BTIG Research
    6/24/2024Hold
    Argus
    More analyst ratings

    $SOLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KeyBanc Capital Markets initiated coverage on Solventum Corporation

      KeyBanc Capital Markets initiated coverage of Solventum Corporation with a rating of Sector Weight

      6/6/25 8:37:20 AM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Solventum Corporation upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Solventum Corporation from Neutral to Overweight and set a new price target of $87.00

      5/19/25 8:47:51 AM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Mizuho initiated coverage on Solventum Corporation with a new price target

      Mizuho initiated coverage of Solventum Corporation with a rating of Neutral and set a new price target of $70.00

      12/4/24 7:49:27 AM ET
      $SOLV
      Medical/Dental Instruments
      Health Care